AS
Insider
Alvin Shih
DirectorAlvin Shih (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Zevra Therapeutics, Inc. (ZVRA). Across 1 priced purchase filing, the average 21-session return was +39.0% from execution and +38.3% from disclosure (delay-adjusted; derived). The largest single filing was $158K of ZVRA (20,000 sh × $7.89, as filed), executed Sep 12 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+39.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+38.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$158K
shares × price, as filed
Last traded
Sep 12 2025
Filed Sep 15 2025
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $158K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ZVRARecent filings
ZVRAPURCHASE
Zevra Therapeutics, Inc.
View filing →
$158K20,000 sh × $7.89
Exec Sep 12 2025
Filed Sep 15 2025 · 4:07 PM ET